Top View
- Jack Deruiter, Principles of Drug Action 2, Fall 2001
- Pergolide Mesylate Can Improve Sexual Dysfunction in Patients with Parkinson’S Disease: the Results of an Open, Prospective, 6-Month Follow-Up
- A Case of Constrictive Pericarditis During Cabergoline Treatment For
- Deep Learning Integration of Molecular and Interactome Data for Protein–Compound Interaction Prediction Narumi Watanabe, Yuuto Ohnuki and Yasubumi Sakakibara*
- Management of Parkinson's Disease During Periods of Fasting
- New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A
- TEACHERS' TOPICS Ergot and Its Alkaloids
- Rotigotine Patches (Neupro®) in the Treatment of Parkinson's Disease
- Chronic Pericardial Constriction Linked to the Antiparkinsonian Dopamine Agonist Pergolide K P Balachandran, D Stewart, G a Berg, K G Oldroyd
- PERGOLIDE (Veterinary—Systemic)
- HHS Public Access Author Manuscript
- Summary of Product Characteristics
- Recent Progress in Ergot Alkaloid Research†
- Australian Public Assessment Report for Rotigotine
- Cirrus® / Zyrtec-D® 5 Mg/120 Mg Tablets
- Use of Apomorphine in Parkinsonian with Neuropsychiatric
- MR Lee, MR Lee
- Apomorphine (APO-Go)
- Inhibitory Effects of Pergolide and Cabergoline Formulations on Daily
- Neupro, INN-Rotigotine
- 2019 Equine Prohibited Substances List
- Effects of Ergot Alkaloids and Bovine Bodily Fluids on Cytochrome P450 Activity Nicholas Scott Zele L University of Arkansas, Fayetteville
- Therapeutic Class Overview Dopamine Agonists
- Coalescing Beneficial Host and Deleterious Antiparasitic Actions As an Antischistosomal Strategy John D Chan1, Timothy a Day1, Jonathan S Marchant2*
- Us 2019 / 0142851 A1
- ARCI CLASSIFICATION PROGRAM V14.1
- Rotigotine (Neupro®▼)
- Adverse Drug Reactions to Dopamine Agonists: a Comparative Study in the French Pharmacovigilance Database
- Nmslabs 2018 Setup Days / TAT Update Effective: October 15, 2018
- Development of a Biosensor for Ergot Alkaloids
- Discovery and Reconstitution of the Cycloclavine Biosynthetic Pathway - Enzymatic Formation of a Cyclopropyl Group
- CAS Number Index
- Mesh Terms for 2002
- Recent Progress in Ergot Alkaloid Research†
- ERGOT: the Genus Claviceps
- Molecularly Imprinted Polymers Synthesized As Adsorbents for Ergot Alkaloids
- PJP5'2004.Vp:Corelventura
- Emergency Management of Patients of Parkinson's (PDF, 99KB)
- Drug-Induced Mitochondrial Dysfunction: an Emerging Model for Idiosyncratic Drug Toxicity
- Patient Information Leaflet
- National PBM Bulletin
- Novel Ergolinyl Compounds Nitrogen-Substituted in the 8-Position, Their Préparation, and Use As Médicinal Agents
- Chemical Name CAS RN Molecular Formula Specific Sops (-)-2Β
- Evolution of Sedation in Dental Practice: from the Ridiculous to the Sublime
- Pergolide and Cabergoline but Not Lisuride Exhibit Agonist Effi
- (12) Patent Application Publication (10) Pub. No.: US 2010/0222388 A1 Polvino (43) Pub
- AERC Drug Rule Appendices
- Ergot Alkaloids
- Elucidation of the Early Steps of Ergot Alkaloid Synthesis by Pathway Reconstruction in Aspergillus Nidulans
- Nenad Withdrawal AR
- Frequency, Pain of Restless Legs Should Guide Therapy
- Movement Disorders Pharmacology
- Restrictions in Use and Availability of Pharmaceuticals 2010 - 2018
- Natural Ergot Alkaloids in Ocular Pharmacotherapy: Known Molecules for Novel Nanoparticle-Based Delivery Systems
- Supporting Information
- WO 2018/148605 Al 16 August 2018 (16.08.2018) W !P O PCT